Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Revenue
€ 2.5 million
▲ 7% vs 2024
Profit
Caution€ -1.2 million
▼ 1320% vs 2024
Debts
Low€ 4.8 million
▲ 63% vs 2024
Ceres Invest from Gent, company number BE0775683264, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year Ceres Invest recorded revenue of € 2.5 million and equity of € 79.1 million. Compared with financial year 2024, the result moved from € -87,277 to € -1.2 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
What happened at Ceres Invest?
What happened at Ceres Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.2 million. Source: NBB ↗
- Naxicap Partners BO became a director. NBB
- New establishment in Gent. KBO
- Mario Debel became a director. NBB
- Emmanuelle Pierret became a director. NBB
- Axel Bernia became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.9 million loss in 2022 to € 1.2 million loss in 2025.
Paid € 2,292 in corporate taxes since 2022.
Pays suppliers within 185 days on average.
A new publication or filing at Ceres Invest? We notify you, reason included.
Follow Ceres InvestNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Ceres Invest are Mario Debel, Emmanuelle Pierret, Naxicap Partners BO and Axel Bernia. It owns 100% of Ceres Pharma itself.
Directors
According to the 2025 annual accounts
Mario Debel
Director
since 2021
Emmanuelle Pierret
Director
since 2021
Director · represented by Dimitri Dumoulin
Also active at: Prime Parts Solution Group
since 2021
Axel Bernia
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1091 box B
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
Ceres Pharmaceuticals
€ 14.6 million revenue · 2025
What's Cooking Group
KOUTERLOS
€ 55,337 gross margin · 2024
b+pharma Belgium
€ 287,023 gross margin · 2025
DGPharma
€ 94,120 gross margin · 2024
+15 more
Details
- Company number
- 0775.683.264
- VAT number
- BE 0775.683.264
- Registered office
- Kortrijksesteenweg 1091 bus B, 9051 Gent
- Names & denominations
- Ceres Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 October 2021
- Peppol
- Active · Active since 17 Jul 2025
- Activities · NACE
Activiteiten van holdings
Holdings